CSRP2BP antibody
Principal name
CSRP2BP antibody
Alternative names for CSRP2BP antibody
CSRP2-binding protein, Cysteine-rich protein 2-binding protein
Ncbi ID
9606, NM_020536, NP_065397.3, NP_852082.2, NM_001166640, NM_181417, NM_177926
Available reactivities
Available hosts
Available applications
ELISA (detection) (E(detection)), Western blot / Immunoblot (WB)
Background of CSRP2BP antibody
- Kit Component:
- - KN303921G1, Csrp2bp gRNA vector 1 in pCas-Guide vector
- KN303921G2, Csrp2bp gRNA vector 2 in pCas-Guide vector
- KN303921D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Western Blot analysis of CSRP2BP expression in transfected 293T cell line (H00057325-T01) by CSRP2BP MaxPab polyclonal antibody.Lane 1: CSRP2BP transfected lysate(86.02 KDa).Lane 2: Non-transfected lysate.
Lysates
| Catalog No. | ||
|---|---|---|
| LY412416 | CSRP2BP overexpression lysate |
|
 |
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR216639L2V | Lenti ORF particles, Csrp2bp (GFP-tagged) - Mouse cysteine and glycine-rich protein 2 binding protein (Csrp2bp), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,580.00
|
|
| OriGene Technologies, Inc. | ||
| MR210607L2V | Lenti ORF particles, Csrp2bp (GFP-tagged) - Mouse cysteine and glycine-rich protein 2 binding protein (Csrp2bp), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,470.00
|
|
| OriGene Technologies, Inc. | ||
| MR216639L1V | Lenti ORF particles, Csrp2bp (Myc-DDK-tagged) - Mouse cysteine and glycine-rich protein 2 binding protein (Csrp2bp), transcript variant 1, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,420.00
|
|
| OriGene Technologies, Inc. | ||
| MR210607L1V | Lenti ORF particles, Csrp2bp (Myc-DDK-tagged) - Mouse cysteine and glycine-rich protein 2 binding protein (Csrp2bp), transcript variant 2, 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,330.00
|
|
| OriGene Technologies, Inc. | ||
